HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Predicting serum ferritin levels in patients with iron overload treated with the film-coated tablet of deferasirox during the ECLIPSE study.

AuthorsAli T Taher, Sebastian Weber, Jackie Han, Andreas Bruederle, John B Porter
JournalAmerican journal of hematology (Am J Hematol) Vol. 94 Issue 1 Pg. E15-E17 (01 2019) ISSN: 1096-8652 [Electronic] United States
PMID30346059 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Iron Chelating Agents
  • Tablets
  • Ferritins
  • Deferasirox
Topics
  • Adolescent
  • Adult
  • Blood Transfusion
  • Child
  • Clinical Trials, Phase II as Topic
  • Deferasirox (administration & dosage, pharmacology)
  • Double-Blind Method
  • Female
  • Ferritins (blood)
  • Hematologic Diseases (blood, therapy)
  • Humans
  • Iron Chelating Agents (administration & dosage, pharmacology)
  • Iron Overload (blood, drug therapy, etiology)
  • Male
  • Models, Biological
  • Multicenter Studies as Topic
  • Patient Acceptance of Health Care
  • Randomized Controlled Trials as Topic
  • Tablets
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: